Lundquist Institute For Biomedical Innovation At Harbor-ucla Medical Center
Clinical trials sponsored by Lundquist Institute For Biomedical Innovation At Harbor-ucla Medical Center, explained in plain language.
-
Could a common antidote help stroke patients?
Disease control CompletedThis study tested whether giving N-Acetylcysteine (NAC) through a vein could help people having an acute ischemic stroke. NAC is an antioxidant already used safely for other conditions. The trial enrolled 4 adults with stroke symptoms, giving them NAC or a placebo for 20 hours. R…
Phase: PHASE2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
Baby bottle diet may stop obesity before it starts
Prevention CompletedThis study tested a simple idea: carefully measuring and limiting the amount of milk or formula given to babies of overweight or obese mothers. The goal was to see if this could prevent the babies from becoming overweight by 6 months old. 60 mothers and their infants took part, w…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Prevention
Last updated Apr 30, 2026 15:51 UTC
-
Shock therapy for bladder control: At-Home device could replace clinic visits
Symptom relief CompletedThis study looked at whether a simple, at-home nerve stimulation treatment (TTNS) can help people with overactive bladder as much as the standard in-clinic version (PTNS). About 70 patients from a county hospital tried one of the two treatments and reported their symptoms and sat…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief
Last updated Apr 30, 2026 15:50 UTC
-
Bladder relief: monthly or On-Demand? new study explores best maintenance plan
Symptom relief CompletedThis study looked at two ways to continue nerve stimulation therapy for overactive bladder in women who had already completed 12 weekly sessions. One group received a monthly maintenance session, while the other could request sessions as needed. The goal was to see which approach…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief
Last updated Apr 29, 2026 15:03 UTC